Clinical and research tests for C1959620 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First < Prev

Page 2 of 5

Results: 21 to 40 of 92

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
DPYD Invitae United States	1	1	T Targeted variant analysis
Lysosomal Storage Disorders Panel PreventionGenetics United States	243	146	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Dihydropyrimidine dehydrogenase deficiency, 274270, Autosomal recessive (Dihydropyrimidine dehydrogenase deficiency) (MLPA) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	D Deletion/duplication analysis
Dihydropyrimidine dehydrogenase deficiency, 274270, Autosomal recessive (Dihydropyrimidine dehydrogenase deficiency) (DPYD gene) (Sequence Analysis-All Coding Exons) (Prenatal) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	C Sequence analysis of the entire coding region
Dihydropyrimidine dehydrogenase deficiency, 274270, Autosomal recessive (Dihydropyrimidine dehydrogenase deficiency) (DPYD gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	C Sequence analysis of the entire coding region
Dihydropyrimidine dehydrogenase deficiency, 274270, Autosomal recessive (Dihydropyrimidine dehydrogenase deficiency) (Prenatal) (MLPA) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	D Deletion/duplication analysis
5-fluorouracil toxicity, 274270, Autosomal recessive (Dihydropyrimidine dehydrogenase deficiency) (MLPA) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	D Deletion/duplication analysis
5 fluorouracil toxicity (DPD gene - Allel 2A-IVS14+1G-A and 3,4,5A,7,8,9,10,12,*13, M166V, R886H, D949V allels) (SnapShot analysis) (DPYD gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	C Sequence analysis of the entire coding region
5-fluorouracil toxicity, 274270, Autosomal recessive (Dihydropyrimidine dehydrogenase deficiency) (DPYD gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	C Sequence analysis of the entire coding region
Pharmacogenomics Test Panel IU Genetic Testing Laboratories Indiana University School of Medicine United States	8	13	T Targeted variant analysis
DPYD Genotyping IU Genetic Testing Laboratories Indiana University School of Medicine United States	1	1	T Targeted variant analysis
DPYD. Complete sequencing IGENOMIX Spain	1	1	C Sequence analysis of the entire coding region
DPYD. Detection of the mutation IVS14 1G>A by sequencing IGENOMIX Spain	1	1	T Targeted variant analysis
Dihydropyrimidine Dehydrogenase Deficiency via the DPYD Gene PreventionGenetics United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Targeted Variant Analysis Integrated Genetics Westborough LabCorp United States	330	748	T Targeted variant analysis
Targeted Variant, Fetal Analysis Integrated Genetics Westborough LabCorp United States	292	597	T Targeted variant analysis
GeneSeq PLUS Integrated Genetics Westborough LabCorp United States	330	748	C Sequence analysis of the entire coding region
GeneSeq PLUS, Fetal Analysis Integrated Genetics Westborough LabCorp United States	292	597	C Sequence analysis of the entire coding region
Partner Reflex to GeneSeq Integrated Genetics Westborough LabCorp United States	330	748	C Sequence analysis of the entire coding region
Inheritest 300 PLUS Panel Integrated Genetics Westborough LabCorp United States	172	350	D Deletion/duplication analysis X Mutation scanning of select exons C Sequence analysis of the entire coding region

<< First < Prev

Page 2 of 5

Results: 21 to 40 of 92

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.